thiazoles has been researched along with miltefosine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 11 (68.75) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, MR; Sobottka, SB | 1 |
Lobovská, A; Nohýnková, E | 1 |
Bories, C; Bréard, J; Loiseau, PM; Paris, C | 1 |
Dey, CS; Verma, NK | 1 |
Bandyopadhyay, S; Chatterjee, M; Dutta, A; Mandal, C | 1 |
Bandyopadhyay, S; Chatterjee, M; Ganguly, S; Sarkar, A | 1 |
Bouchaud, O; Izri, A | 1 |
Ben Brahim, M; Bories, C; Le Moyec, L; Loiseau, PM; Rakotomanga, M; Saint-Pierre-Chazalet, M | 1 |
Mesquita, JT; Reimão, JQ; Tempone, AG | 1 |
Chong, LS; Epp, JB; Fu, Q; Groutas, WC; He, S; Kuang, R; Li, YH; Ruan, S; Truong, TM; Tu, J; Venkataraman, R; Vu, NT; Yu, H | 1 |
Chan, HK; Groutas, WC; He, S; Kuang, R; Ruan, S; Tu, J | 1 |
Alliston, KR; Gan, X; Groutas, WC; Lai, Z; Li, YH; Wei, L; Yu, H | 1 |
Alliston, KR; Dou, D; Groutas, WC; Hanzlik, RP; Huang, W; Li, Y; Williams, TD; Yamamoto, Y | 1 |
Dou, D; Fu, Q; Groutas, WC; He, G; Kuang, R; Venkataraman, R | 1 |
Caram, JA; Castro, EA; Duchowicz, PR; Fernández, FM; García, J; Mirífico, MV; Rozas, MF | 1 |
Cummings, AH; Gates, KS; Hillebrand, R; Laciak, AR; Lewis, SM; Punthasee, P; Ruddraraju, KV; Singh, H; Tanner, JJ | 1 |
1 review(s) available for thiazoles and miltefosine
Article | Year |
---|---|
[New drugs for treatment of parasitic infections].
Topics: Antiparasitic Agents; Humans; Intestinal Diseases, Parasitic; Leishmaniasis; Nitro Compounds; Phosphorylcholine; Thiazoles | 2003 |
15 other study(ies) available for thiazoles and miltefosine
Article | Year |
---|---|
Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
Topics: Animals; Antineoplastic Agents; Cell Count; Cell Division; Coloring Agents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Nitrosourea Compounds; Phosphorylcholine; Rats; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vinblastine | 1992 |
Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Cell Cycle; Chromatography, Agarose; Colorimetry; DNA Fragmentation; Flow Cytometry; Leishmania donovani; Phosphatidylserines; Phosphorylcholine; Protease Inhibitors; Tetrazolium Salts; Thiazoles | 2004 |
Possible mechanism of miltefosine-mediated death of Leishmania donovani.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Cell Division; Coloring Agents; Cricetinae; Cricetulus; DNA Fragmentation; DNA, Protozoan; In Situ Nick-End Labeling; Indicators and Reagents; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Nucleosomes; Phosphorylcholine; Poly(ADP-ribose) Polymerases; Propidium; Tetrazolium Salts; Thiazoles | 2004 |
Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral; Parasitic Sensitivity Tests; Phosphorylcholine; Tetrazolium Salts; Thiazoles | 2005 |
Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Colorimetry; Drug Evaluation, Preclinical; Humans; Indicators and Reagents; Inhibitory Concentration 50; Kinetics; Leishmania; Leishmania donovani; Leishmaniasis, Visceral; Pentamidine; Phosphorylcholine; Tetrazolium Salts; Thiazoles | 2006 |
[New antiparasitic drugs].
Topics: Albendazole; Antimalarials; Antiparasitic Agents; Benzimidazoles; Cyclohexanes; Fatty Acids, Unsaturated; Humans; Ivermectin; Nitro Compounds; Phosphorylcholine; Praziquantel; Sesquiterpenes; Thiazoles; Triclabendazole | 2008 |
Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.
Topics: Animals; Antiprotozoal Agents; Cell Membrane; Drug Resistance; Leishmania donovani; Lipid Metabolism; Microbial Viability; Mitochondria; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Phosphorylcholine; Sterols; Tetrazolium Salts; Thiazoles | 2009 |
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles | 2014 |
1,2,5-Thiadiazolidin-3-one 1,1 dioxide: a powerful scaffold for probing the S' subsites of (chymo)trypsin-like serine proteases.
Topics: Cathepsin G; Cathepsins; Chymotrypsin; Cyclic S-Oxides; Humans; Kinetics; Leukocyte Elastase; Models, Chemical; Molecular Probes; Myeloblastin; Protein Binding; Serine Endopeptidases; Temperature; Thiazoles; Time Factors | 2001 |
Inhibition of serine proteases by functionalized sulfonamides coupled to the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold.
Topics: Cathepsin G; Cathepsins; Cyclic S-Oxides; Drug Design; Leukocyte Elastase; Models, Molecular; Myeloblastin; Serine Endopeptidases; Serine Proteinase Inhibitors; Structure-Activity Relationship; Sulfonamides; Thiazoles | 2001 |
Potent inhibition of human leukocyte elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamide derivatives.
Topics: Cyclic S-Oxides; Enzyme Inhibitors; Humans; Leukocyte Elastase; Magnetic Resonance Spectroscopy; Sulfonamides; Thiazoles | 2004 |
X-ray snapshot of the mechanism of inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives.
Topics: Binding Sites; Crystallography, X-Ray; Cyclic S-Oxides; Enzyme Activation; Humans; Leukocyte Elastase; Models, Molecular; Molecular Structure; Protein Structure, Tertiary; Serine Proteinase Inhibitors; Structure-Activity Relationship; Thiazoles | 2008 |
Effects of structure on inhibitory activity in a series of mechanism-based inhibitors of human neutrophil elastase.
Topics: Cyclic S-Oxides; Humans; Kinetics; Leukocyte Elastase; Myeloblastin; Protease Inhibitors; Thiazoles | 2010 |
A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases.
Topics: Cyclic S-Oxides; Drug Design; Humans; Linear Models; Molecular Conformation; Molecular Dynamics Simulation; Quantitative Structure-Activity Relationship; Serine Proteases; Serine Proteinase Inhibitors; Thiazoles | 2011 |
Covalent Allosteric Inactivation of Protein Tyrosine Phosphatase 1B (PTP1B) by an Inhibitor-Electrophile Conjugate.
Topics: Allosteric Regulation; Allosteric Site; Binding Sites; Crystallography, X-Ray; Cyclic S-Oxides; Enzyme Inhibitors; Escherichia coli; Gene Expression; Humans; Kinetics; Mutation; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Recombinant Proteins; Structure-Activity Relationship; Thermodynamics; Thiazoles | 2017 |